Amygdala Insula Retraining in the Management of Multiple Sclerosis Sym
Amygdala Insula Retraining in the Management of Multiple Sclerosis Symptoms
We could not find results for this trial
What it found
We found no results in the registry or in papers.
This trial finished 19 months ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Amygdala insula retraining
- Lifestyle program
What it measured
Main measures
Fatigue Severity Scale
Baseline (Week 0) to post-intervention (Week 12)
Fatigue
Other measures (5)
PROMIS Pain Interference 8a
Baseline (Week 0) to post-intervention (Week 12)
PainEQ-5D (quality of life)
Baseline (Week 0) to post-intervention (Week 12)
Quality of life (reported by participants)GAD-7 (anxiety)
Baseline (Week 0) to post-intervention (Week 12)
Mood and sleepPHQ-9 (depression, with suicidality item excluded)
Baseline (Week 0) to post-intervention (Week 12)
Mood and sleepMSQ-Revised (exploratory)
Baseline (Week 0) to post-intervention (Week 12)
Who could take part
MS (type not specified) · 21 to 65
Show the full criteria
Inclusion criteria
* Confirmed multiple sclerosis diagnosis
Exclusion criteria
* Previous experience with brain retaining programs
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The goal of this study is to compare a lifestyle intervention and a mind-body intervention against a wait-list control in individuals with multiple sclerosis experiencing persistent symptoms. Our research questions include: Are lifestyle and mind-body interventions additive to usual care in MS? Can these interventions improve MS symptoms and overall quality of life?
Loading reviews and guidelines…
History
Started
Sept 2024
Main results due
Mar 2025
Finished
Mar 2025